← Alle events

Clinical trials: The bridge to an optimal registration

Van derden


Find the gaps together with us at the ProPharma Group Centre of Excellence; a life cycle approach

Will your clinical development in the future deliver new treatment options? Solid science will always be a foundation, but a successful development process stretches beyond scientific opportunities. Find the gaps and apply a life cycle approach for product development.

Professor Doctor Annemieke Aartsma-Rus will inform you on the lessons learned from a failure of a registration trial on a Duchenne muscular dystrophy treatment.

Step into the world of Phase II studies based on a multidisciplinary approach and strategy building. Discuss topics as dose finding, comparator picking, epidemiology, and dosing formulations. Focus on small (Phase II/III) studies on rare diseases.


  • 16.30 Doors open
  • 17.00 Welcome
  • 17.15 – 18.15 Annemieke Aartsma-Rus (Professor of translational genetics, LUMC), Therapy development for rare diseases takes more than a therapeutic compound
  • 18.15 – 19.00 Thomas de Vlaam (Founder and CEO, Amylon Therapeutics): Industry perspective
  • 19.00 – 19.30 ProPharma Group: Regulatory affairs
  • 19.30 Drinks & Networking
  • 20.30 Close


Register for free at reception@xendo.com


Kaart wordt geladen...